| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 76.98× | 76.98× | 78.11× | 81.35× | 72.96× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.26× | 2.84× | 3.03× | 3.25× | 3.98× | ||
| 1.59× | 1.59× | 1.64× | 1.79× | 1.87× | ||
| 1.47× | 1.47× | 1.16× | 1.84× | 0.50× | ||
| 0.91× | 0.91× | 0.71× | 1.19× | 0.21× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 72.96 | 81.35 | 78.11 | 76.98 | 76.98 | |
| Working Capital Turnover | 3.98 | 3.25 | 3.03 | 2.84 | 3.26 | |
| Asset Turnover | 1.87 | 1.79 | 1.64 | 1.59 | 1.59 | |
| Cash Conversion (CFO/Net Income) | 0.50 | 1.84 | 1.16 | 1.47 | 1.47 | |
| CFO/EBITDA | 0.21 | 1.19 | 0.71 | 0.91 | 0.91 |